| ISIN | IE00BK5H8015 |
|---|---|
| Valor Number | 49894453 |
| Bloomberg Global ID | |
| Fund Name | SPDR® STOXX Europe 600 SRI UCITS ETF EUR Unhedged (Acc) |
| Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
| Fund Provider | State Street Investment Management |
| Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Ireland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The investment objective of the Fund is to track the performance of European equities. |
| Peculiarities |
| Current Price * | 33.85 EUR | 30.10.2025 |
|---|---|---|
| Previous Price * | 33.90 EUR | 29.10.2025 |
| 52 Week High * | 34.27 EUR | 27.10.2025 |
| 52 Week Low * | 28.37 EUR | 09.04.2025 |
| NAV * | 33.85 EUR | 30.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 507,088,630 | |
| Unit/Share Assets *** | 507,088,630 | |
| Trading Information SIX | ||
| YTD Performance | +10.88% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +9.49% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
| 1 month | +3.06% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 months | +4.57% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 months | +6.08% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 year | +9.15% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 years | +38.00% |
30.10.2023 - 30.10.2025
30.10.2023 30.10.2025 |
| 3 years | +49.71% |
31.10.2022 - 30.10.2025
31.10.2022 30.10.2025 |
| 5 years | +88.92% |
30.10.2020 - 30.10.2025
30.10.2020 30.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 5.95% | |
|---|---|---|
| SAP SE | 4.24% | |
| Novartis AG Registered Shares | 3.76% | |
| Nestle SA | 3.68% | |
| AstraZeneca PLC | 3.62% | |
| Roche Holding AG | 3.55% | |
| Novo Nordisk AS Class B | 2.71% | |
| Allianz SE | 2.52% | |
| Schneider Electric SE | 2.51% | |
| Unilever PLC | 2.32% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.12% |
|---|---|
| TER date *** | 31.03.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.12% |
| Ongoing Charges *** | 0.12% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |